Opioids are used to alleviate pain however ~10–30% of the Caucasian population obtain ineffective pain relief and / or intolerable side effects. Genetic polymorphisms in opioid pharmacodynamic and pharmacokinetic important genes have been investigated however there has been a lack of conclusive results. Epigenetic gene regulation is another study field of interest. DNA methylation is a gene regulatory mechanism that has been associated with gene repression or expression. Thus it was hypothesised that variable opioid response was influenced by methylation alterations. The promoter region methylation of ABCB1/MDR1, CYP2D6 and OPRM1 genes were analysed by pyrosequencing in smoking, opioid exposed and control pilot populations. Genetic variatio...
Background: Genetic polymorphisms in genes involved in pain modulation have been reported to be asso...
Abstract Background Glial cells in the central nervou...
Abstract Inter-individual variation in response to opioids for cancer pain is a well-established phe...
Aim: To identify differential methylation related to prescribed opioid use. Methods: This study exam...
Aim: Exposure to opioids has been associated with epigenetic effects. Studies in rodents suggested a...
OBJECTIVE: To investigate whether in utero opioid exposure, which has been linked to adverse neurode...
We conducted the first large-scale epigenome-wide meta-analysis of blood DNA methylation and recent ...
Addiction and tolerance develop with the chronic use of opioids. Opioid drug abuse has social, econo...
Pain is one of the most persistent and incapacitating symptoms of cancer. In fact, unsatisfactory tr...
Abstract Opioid use disorder (OUD) is influenced by genetic and environmental factors. While recent ...
Background Glial cells in the central nervous system play a key role in neuroinflammation and subseq...
This study aimed to investigate DNA methylation levels in patients undergoing major breast surgery u...
Opioids are used for acute and chronic pain and dependency. They have a narrow therapeutic index and...
Cancer pain patients need variable opioid doses. Preclinical and clinical studies suggest that opioi...
Background: Genetic polymorphisms in genes involved in pain modulation have been reported to be asso...
Background: Genetic polymorphisms in genes involved in pain modulation have been reported to be asso...
Abstract Background Glial cells in the central nervou...
Abstract Inter-individual variation in response to opioids for cancer pain is a well-established phe...
Aim: To identify differential methylation related to prescribed opioid use. Methods: This study exam...
Aim: Exposure to opioids has been associated with epigenetic effects. Studies in rodents suggested a...
OBJECTIVE: To investigate whether in utero opioid exposure, which has been linked to adverse neurode...
We conducted the first large-scale epigenome-wide meta-analysis of blood DNA methylation and recent ...
Addiction and tolerance develop with the chronic use of opioids. Opioid drug abuse has social, econo...
Pain is one of the most persistent and incapacitating symptoms of cancer. In fact, unsatisfactory tr...
Abstract Opioid use disorder (OUD) is influenced by genetic and environmental factors. While recent ...
Background Glial cells in the central nervous system play a key role in neuroinflammation and subseq...
This study aimed to investigate DNA methylation levels in patients undergoing major breast surgery u...
Opioids are used for acute and chronic pain and dependency. They have a narrow therapeutic index and...
Cancer pain patients need variable opioid doses. Preclinical and clinical studies suggest that opioi...
Background: Genetic polymorphisms in genes involved in pain modulation have been reported to be asso...
Background: Genetic polymorphisms in genes involved in pain modulation have been reported to be asso...
Abstract Background Glial cells in the central nervou...
Abstract Inter-individual variation in response to opioids for cancer pain is a well-established phe...